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2Introduction
H.pylori infection is chronic and common throughout the world with higher
prevalence in developing than in developed countries. H.pylori infection causes
gastritis and is the most prime risk factor for peptic ulcer disease (gastric &
duodenal). It also contributes to the onset of gastric cancer and primary B-cell
lymphomas.
H.pylori is seen in significant number of dyspeptic patients with
endoscopically normal stomach. A strong relationship is also documented
between H.pylori and peptic ulcer disease. It has been classified recently by
WHO as a CLASS I carcinogen because it is involved in the development of
Atrophic gastritis with Intestinal metaplasia (pre-neoplastic gastric lesion). This
bacterium induces a characteristic inflammatory response with an initial
development of acute gastritis, which when prolonged leads to chronic
inflammation.
Inflammation with this micro aerobic, gram negative, spiral, motile
bacterium has become major prime cause for chronic active gastritis. It resides
in the gastric pits and the overlying mucus. H.pylori colonization of stomach is
associated with a spectrum of gastro duodenal disease. H.pylori can receive
signals from gastric epithelium, allowing the host and bacteria to
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participate in a dynamic equilibrium. However, there are biological effects to
this long term relationship.
Chronic inflammation induced by bacteria causes the loss of normal
architecture of gastric mucosa with destruction of glandular gastric cells and
their replacement by the intestinal type epithelium , pyloric type glands , &
fibrous tissue (Atrophic gastritis ). There is an increased risk of developing
gastric cancer with ATROPHY – METAPLASIA – DYSPLASIA sequence.
H.pylori is localised in the apical portion of the gastric foveolar glands and does
not penetrate the gland cytoplasm. H.pylori colonisation usually triggers an
inflammatory reaction in the lamina propria .Mucosal neutrophils are a
distinctive histological feature of H.pylori infection. The grading of activity in
gastritis is done according to MODIFIED SYDNEY SYSTEM.
There are a number of methods for detection of H.pylori, including
the Breath test, Urease test & Culture. But the histological detection in gastric
biopsy is the commonest and more sensitive of all methods. This spiral shaped
organism can be seen in routine H&E stains, but are more easily detected with
special stains such as Giemsa &, Warthin – Starry silver stain .None of these
are more specific for the organism and the coccoid forms and indolent forms are
missed out easily in routine stains. More recently, IMMUNO
HISTOCHEMISTRY, IN SITU HYBRIDISATION & PCR has
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been proposed as alternative & more specific modalities in detection.
Few studies have been done towards this, and found out that
I H C against H.pylori is more specific (66% positivity) followed by Warthin
Starry silver (61% positivity). Hence, I H C is more reliable and accurate in the
cases of coccoid forms and those negative in Genta stains. To extend further ,
this study is focussed , to compare the efficacy of basic staining techniques ,
I H C  & the histological tissue changes in H.pylori associated Chronic
gastritis.
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6Aims & Objectives
1. To study the histopathological changes in the gastric mucosa in
patients with H.pylori associated chronic gastritis.
2. To identify the H.pylori organisms in biopsies on routine H & E and special
stains.
3. Use of anti H.pylori antibody to identify the H.pylori in gastric mucosa.
4. To compare the efficacy of I H C & Special stains
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In this study, we included the gastric biopsies taken from the
patients presenting with complaints of dyspepsia, or clinically suspected
Helicobacter pylori infection. These biopsies once received in our laboratory
were given a unique reference number to identify them later from the archives.
We excluded the biopsy samples taken for conditions other than simple peptic
ulcer disease such as suspected malignancy, GERD, etc.
Sample size is 55, for a period of 1 year duration    (2010-2011).
Overall there were around 700 endoscopy guided biopsy samples received, of
which about 250 were from the stomach, followed by small intestine and
oesophagus.
It is a retrospective study, where we included the cases that were
clinically and histopathologically diagnosed positive for H.pylori infection. We
maintained a routine protocol and proper procedures to access the ARCHIVES
OF DEPARTMENT OF PATHOLOGY, PSG IMS&R. The cases complying
with our inclusion criteria were sorted out and the data were collected regarding
initial report. In most cases it was reported as “H.pylori like organisms “on
H&E stain confirmed by Modified Giemsa which we use in our routine practice.
The tissue blocks were taken out accordingly.
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The samples were taken out randomly and numbered in an order so as to
maintain the data for this study. The H&E and Modified Giemsa slides were
reviewed again .As this study includes the use of Antibody to Detect the
H.pylori, the tissues were also processed separately over Poly – L – Lysine
coated slides.
I. Haematoxylin and Eosin Staining:
Materials required:
 Harris Haematoxylin
 Eosin
 Xylene
 1% Acetic acid
 Ammonia water
 1% Eosin
 Graded Alcohols
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Staining Procedure:
2. HYDRATE
THROUGH GRADED
ALCOHOLS TO
WATER
3. STAIN IN HARRIS
HEMATOXYLIN – 5
MINUTES
4. WASH IN RUNNNING
TAP WATER TILL IT
TURNS BLUE
8.  1% EOSIN FOR ONE
MINUTE
7. DIP IN AMMONIA
WATER, THEN WASH
IN TAP WATER
5. DIFFERENTIATE IN 1%
ACID ALCOHOL – 5- 10
MINUTES
6. WASH IN RUNNNING
TAP WATER TILL IT
TURNS BLUE
9. DEHYDRATE THROUGH
ALCOHOLS, CLEAR AND
MOUNT
1.DEPARAFFINIZE
SECTIONS
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Used as a staining procedure in routine paraffin sections.
RESULTS:
Nuclei – Blue
Cytoplasm – Pink
Red Cells – Orange / Red
Fibrin – Deep pink
H.pylori – pink rods
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II. MODIFIED GIEMSA:
Purpose: To demonstrate the H.pylori organisms
PREPARATION OF SOLUTION:
Giemsa stock solution
Giemsa stain powder – 4gm
Glycerol – 250 ml
Pure methanol – 250 ml
The powder is dissolved in the glycerol at 60º c with regular shaking.  Add
methanol .Mix well. Allow to stand for 7 days. Filter before use.
Working solution
Giemsa stock – 4 ml
Acetate buffered distilled water, pH 6.8 – 96 ml
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PROCEDURE:
1. DEPARAFFINIZE
& REHYDRATE
THROUGH GRADED
ALCOHOLS
3. STAIN IN
WORKING
SOLUTION
OVERNIGHT
7. DEHYDRATE
VERY RAPIDLY
THROUGH
ALCOHOL, CLEAR
AND MOUNT
5. RINSE IN 0.5%
AQUEOUS ACETIC
ACID, UNTIL
SECTION ARE PINK
4. RINSE IN
DISTILLED WATER
2. RINSE SECTION
IN DISTILLED
WATER
6. WASH IN TAP
WATER, BLOT
UNTIL ALMOST
DRY
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RESULTS:
Organisms – bluish
Background – pink to blue
Nuclei – Blue
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III. STAINING USING ANTIBODY:
i). Sections are cut at approximately 4µm , floated on to Poly – L – Lysine
coated slides and incubated at 37ºc for one day and further incubated at 58ºc for
overnight.
Note:
ii). Xylene – I - 15 min                Deparaffinization
Xylene – II - 15 min
iii). Absolute Alcohol – I - 1 min                  Dexylenization
Absolute Alcohol – II - 1 min
iv). 90% Alcohol - 1 min Dealcoholisation
70% Alcohol - 1 min
 Do not allow sections to dry at
any stage of the procedure
 Carry out the steps of incubation
with antibody at 37ºc
 Use appropriate controls for
each antibody tested
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v). Tap water - 10 min     Rehydration
vi). Distilled water - 5 min       Rinsing
vii). Pressure cooked in 10 min – Heat induced Antigen
Citrate buffer (pH- 6) retrieval
viii). Leave the pressure cooker in              20 min – Cooled at room temperature
a sink with water
ix). Distilled water - 5 min        Rinsing
x). Transfer to Trisodium phosphate buffer (pH 7.6) – 5 min × 2 times (wash)
xi). Peroxidase block – 10 to 15 min to block endogenous Peroxidase
Enzyme
xii). TBS buffer - 5 min × 3 times – washing
xiii). Power Block – 15 min to block non specific reaction with
Other tissue antigen
xiv). Drain & cover sections with            1 hour         To identify Tumour
markers
concerned Primary Antibody Ag – Ab reaction
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xv). TBS buffer - 5 min × 3 times – to wash unbound Ab’s
xvi). Super enhancer - 30 min to enhance the reaction
between 1º & 2º antibody
xvii). TBS buffer - 5 min × 3 times – to wash unbound Ab
xviii). Super sensitive poly – HRP – 30 min to elongate chain and also
to label the enzyme
xix). TBS buffer - 5 min × 3 times – to wash unbound Ab
xx). Colour development with working        5-8 min – to give colour to the
colour development solution                          Antigen
xxi). TBS buffer - 5 min × 3 times – to wash
xxii). Tap water - 5 min – to wash
xxiii). Haematoxylin - 1 min – Counterstain
xxiv). Tap water - 5 min – to wash excess stain
xxv). Air Dry, clear in Xylene, Mount with DPX
xxvi). RESULTS: Organism /Tumour markers Brown
Nucleus Blue
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Once the slides were prepared, we placed them separately segregating them into
three stains for each case. They were accompanied by positive controls for the
special stain (Modified Giemsa) and for H.pylori Ab. The controls were used to
compare the morphology of bacterium to term them as “positive “. The slides
were reviewed in the following order: H&E, Modified Giemsa and
H.pylori Antibody.
In H&E we looked for the features suggesting the H.pylori infection,
inflammation grade (Modified Sydney System) and other reactive changes of
the gastric mucosa. Whereas Modified Giemsa was used to correlate the
diagnosis along with the supplementation by the use of immunohistochemistry...
The slides were observed using the LABOMED VISION 2000 microscope.
The representative photomicrographs were taken using the microscope
(LEICA) and Leica Application Suite.
19
REVIEW OF LITERATURE
20
Review of literature
EMBRYOLOGY OF STOMACH:
The stomach in its embryonal stage is seen distal to the oesophagus.
Present as a fusiform dilatation of the foregut1. Have two borders dorsal and
ventral. Dorsal being attached to the posterior abdominal wall by a fold of
peritoneum called the dorsal mesogastrium. Ventral border being attached to
the septum transversum by another fold of peritoneum called the ventral
Mesogastrium. The part of the ventral mesogastrium between the liver and
stomach becomes lesser omentum. The stomach undergoes differential growth
resulting in alteration in shape & orientation. The ventral border faces upwards
and then left to form lesser curvature. The dorsal border points downwards and
then left, to form greater curvature. Enzyme and acid production first occur at
the fourth month of foetal life & are well established by the time of birth1. The
new born stomach is fully developed and is similar to that of the adults.
Stomach develops from the endoderm, and the early glandular differentiation
of the mucosal lining occurs first at the 80 mm stage of foetal development.
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ANATOMY OF STOMACH:
The stomach is a sac like structure2, reservoir for swallowed
food. With a capacity of one litre, it is the dilated part of the alimentary canal. It
is capable of varying its shape and size depending on the amount of food
content. Anatomically described to have two ends, the cranial & caudal 2. The
former being continuous with the oesophagus and located towards the heart
apex, it is also termed as “cardiac end “. The caudal end continues downwards
distally into the duodenum, also termed as “ pyloric end / pylorus “.
The anterior and posterior surfaces of the stomach meet at a concave upper
border & a convex lower border. These are termed as lesser curvature &
greater curvature respectively.2
The stomach is lined by peritoneum, covering both the surfaces
and coalesces at the lesser curvature to continue with lesser omentum. At the
greater curvature, the anterior and posterior layers of peritoneum become
continuous with gastro-splenic ligament and with greater omentum.
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Anatomically, stomach is divided into many parts as follows:
A. The left margin of oesophagus and greater
curvature junction Cardiac notch
B. Fundus
C. Body
D. Pyloric antrum
23
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HISTOLOGY OF STOMACH:
Microscopically, the mucosa has a similar pattern
throughout the stomach 3. It is composed of superficial layer containing
foveolae (pits). The deep layer comprises of coiled glands that empty into the
base of the foveolae. Adjacent to the gastro -oesophageal junction of the cardiac
mucosa the glands are mucus secreting.3
Surface epithelium consists of tall, columnar, mucus
secreting cells with intervening foveolar epithelium. The cells are tall, columnar
with basal nuclei and superficial cytoplasm filled with mucus. Histochemically,
the foveolar mucus is all Neutral, Periodic Acid Schiff (P A S) positive 9,
but Alcian Blue negative at pH 2.5 and lower.
In the Cardiac & Pyloric zone, the foveolae occupy
approximately one half of mucosal thickness. The glands
secrete mucus , loosely packed within the lamina propria 3 .The cells of the
mucus glands have ill defined cell borders , bubbly cytoplasm that
is different from foveolar and surface epithelium . The pyloric glands secrete
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neutral mucin only. The cardiac glands secrete predominantly neutral mucin
with small amount of sialomucin9.
The fundic gland or oxyntic gland mucosa has foveolae that
occupy less than a quarter of the mucosal thickness 3. In contrast to pyloric and
cardiac mucosa, the glands are tightly packed and are straight, rather than being
coiled .These are divided into 3 portions .The basal portion consists mainly of
zymogenic cells. These are cuboidal & have basal nucleus and moderate amount
of cytoplasm. The isthmic portion of glands contains predominantly parietal
cells (acid and intrinsic factor secreting). These cells are roughly triangular 4,
with their base along the basement membrane. The nucleus is centrally placed
with abundant eosinophilic cytoplasm. The Neck portion of fundic gland
contains mixture of zymogen and parietal cells along with mucus neck cells.
These cells produce neutral and acidic mucin, especially sialomucin which
stains Alcian Blue, positivity at pH 2.5 9.
ENDOCRINE CELLS:
In antrum, 50 % of the population are G cells (gastrin
producing), 30 % are enterochromaffin cells (serotonin producing) & 15 % are
D cells (somatostatin producing). In the fundic mucosa, major portion of
25
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endocrine cells are enterochromaffin – like cells (ECL) and secrete histamine.
Small numbers of X cells and EC cells are also present 3.
LAMINA PROPRIA:
The epithelial cells of the surface, foveolae and glands are
supported by a fine meshwork of reticulin, collagen and elastic fibres suspended
beneath the basement membrane. These give structural support to the overlying
epithelium. Lamina propria contains fibroblasts, histiocytes, plasma cells,
lymphocytes. There are capillaries, arterioles & non myelinated nerve fibres
.Intraepithelial lymphocytes are also seen and are of Tell origin. Normally there
may be lymphoid aggregates 5, 32. However, secondary lymphoid follicles with
germinal centre are seen in gastritis, usually secondary to H.pylori infection 7.
SUB MUCOSA:
It is located between the muscularis mucosa and lamina
propria; it consists of loose connective tissue, autonomic nerve plexus, veins
arteries & lymphatics 7.
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MUSCULAR LAYER:
The muscularis mucosa consists of inner circular and outer
longitudinal layers. The muscularis propria has three layers outer longitudinal,
inner circular & innermost oblique.
27
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HISTORICAL ASPECTS:
It was described in 1983; the spiral shaped organisms
resembling Campylobacteria were isolated from the stomach and were named
as, C.pylori8. In 1989 it was renamed as Helicobacter pylori. In 1947, in the
outset of gastroscopy, Rudolf Schindler termed the gastritis as “one of the most
debated diseases of the human body”. The discussion on terming gastritis was
started since 1800’s and in early 20th century after mixed views and discussions,
the concept of gastritis as a disease entity was detained. Later after many
decades, the term gastritis was finally recognized, and the search for cause,
classification and complications began to bloom.
Since 1870, the presence of tiny curved bacterium within gastric mucosa had
been described in both humans and in animals. But they were thought to be
irrelevant contaminants and were ruled out 6. Apart from the bacterium, various
etiologic factors were described, such as nicotine, improper mastication, spices,
drugs, etc. Subsequently several morphological data were obtained by
pathologists on autopsy specimens. As a result, distinct types and patterns of
gastritis were recognised and many classification systems were outlined 11.
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Later in 1984, Warren &Marshall proposed that chronic idiopathic gastritis
had a bacterial cause (i.e. H.pylori) 37. This hypothesis led to further research,
analysis and proposals and later in few years, the association between H.pylori
gastritis, peptic ulcer and gastric cancer became recognised and ultimately
accepted. In 1990, guidelines for gastritis were described by a group of
investigators in Sydney, Australia 5. This system for grading and classification
of gastritis is accepted universally as “SYDNEY SYSTEM “. Subsequently, this
system is updated periodically and modifications were added in an idea to
improve the criteria for evaluation of atrophy. Sydney system combines
topographic, morphologic and etiological factors for relevant possible
diagnoses.
EPIDEMIOLOGY:
The prevalence of H.pylori infection in adults reaches 90% in
many developing countries 26. These bacteria are regarded as the main
etiological factor for the asymptomatic non specific gastritis. In developing
countries, due to other co- morbid conditions, dietary variations, etc. The
H.pylori infection is on rise worldwide5. Cross sectional studies have revealed a
higher prevalence rate of infection in children. In industrialized parts of the
world (Western Europe, Canada, US, Australia), the exposure tends to occur in
adulthood11.
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An average of 20% to 30% adults is infected by the age of 50. In
Eastern Asia due to proper implementation of sanitation methods, there is a
decline in the incidence of H.pylori infection.
The prevalence of H.pylori infection has been steadily declining in
industrialized and emerging countries. This is mainly due to proper sanitation
and wide use of prophylactic antibiotics 8.
Despite the declining rates of H.pylori infection in general, the
prevalence rate of H.pylori in patients undergoing endoscopy remains
significant. Therefore, H.pylori should be considered in all gastric biopsy
specimens examined, regardless of patient’s age.
MORPHOLOGIC CHARACTERISTICS:
Helix shaped, Curved, micro aerophilic, flagellated, gram negative
rods measuring 3micrometres long & 0.5 micrometres diameter 18.
These organisms produce oxidase; catalase & urease16 .These
organisms show urease positivity and are found in the gastric biopsy specimens,
most common in antrum19. It is eminent in forming bio film & can convert itself
from spiral into a possibly viable but non-culturable coccoid forms 21.
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H.pylori possesses 5 major outer membrane protein (OMP)
families. Largest family include putative adhesins. The other four include
porins, iron transferrin, flagellum associated protein. Outer membrane consists
of phospholipids & lipopolysaccharides (LPS). The O Ag of
Lipopolysaccharides may be fucosylated and mimic Lewis blood group Ag
found in gastric epithelium 22. These organisms are highly motile, fastidious due
to flagella which are 4 to 6. The flagellar filaments contain flagellins. (FlaA &
FlaB) 25
GENETICS:
H.pylori, possess large variations of strains. The genomes of three
have been completely sequenced. Genome of strain 26695 consists of about 1.7
million base pairs with around 1550 genes. The 2 sequenced genes show large
genetic differences with up to 6 % of nucleotides differing in them.
The studies on H.pylori genes approached on an aim to describe the
pathogenesis of H.pylori associated diseases, common being gastric ulcer. Two
of the sequenced strains have 40kb long Cag pathogenicity island with over 40
genes. This island is absent in chronic carriers of H.pylori infection and remain
asymptomatic.The Cag A codes for one major virulence protein30. Bacterial
strains that have Cag A gene are associated with an ability to cause Ulcer30.
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Thus by the studies performed we find that virulent cyotoxin Vac A and Cag A
producing strains are more common among patients with
peptic ulcer and gastric cancer. These toxins act as the virulence factors in
enhancing the disease progression30.
PATHOPHYSIOLOGY:
When the pathogen is ingested, the spiral organism enters the
gastro – intestinal tract by counteracting the host defence mechanism by the
motility inducing flagella 30. The host defence mechanism prevents the
bacterium from infection. The defence mechanisms include the acidic pH,
bactericidal agents and the columnar cells secreting the sticky mucus which
blocks the motile bacterium.  After entering the gastric lumen, the bacterium
evades through the host defence by its “cork screw like bacterial movement”
and enzyme production (urease, lipase, protease) 32. It progresses down to the
epithelial surface from mucus and attach to the apical membranes of foveolar
cells, with the help of bacterial adhesin such as BabA . H.pylori in addition
binds to MUC 5A 18. Then it secretes the vacuolating cytotoxin VacA. By
inducing the vacuolating action, it possess the Cag pathogenicity island
facilitating transfer of CagA protein into foveolar epithelium causing cell
response, cytokine production & cell proliferation 15.
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BabA adhesion causes binding to the fucosylated Lewis B blood group antigen
Vac A forms channels which deliver nutrition to H.pylori
Thus by initiating the action of cytokines, the inflammatory response occurs. To
surpass the effect of inflammatory mediators secreted by the host, the H.pylori
releases IL-10 which exhibits the anti inflammatory effect, preventing the
cytokine to secrete the mediators of inflammation 24. Thus it survives the target
action exerted by the body. It stays indolent for long, causing chronic effects on
the gastric mucosa and associated diseases. These post effects are much
deleterious than the acute inflammatory reaction. They vary from simple
chronic gastritis to a malignant lymphoma or carcinoma. Early detection of
these organisms could pave way for the treatment strategy and eradication of
disease in endemic areas 31.
34
Review of literature
H.PYLORI – RELATED Changes in Gastric mucosa
1. ACUTE GASTRITIS
2. CHRONIC GASTRITIS
3. CHRONIC ACTIVE GASTRITIS
4. FOLLICULAR GASTRITIS
5. ATROPHIC GASTRITIS
6. LYMHOCYTIC GASTRITIS
7. GRANULOMATOUS GASTRITIS
8. GASTRIC & DUODENAL ULCERS
9. SOME FORMS OF AUTOIMMUNE GASTRITIS
10. HYPERPLASTIC POLYPS
11. INTESTINAL METAPLASIA
12. G- CELL HYPERPLASIA
13. GASTRIC ADENO CARCINOMA
14. MALT oma
15. MENETRIER DISEASE
35
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CLINICAL OUTCOMES ASSOCIATED WITH   H. PYLORI
INFECTION:
The helicobacter pylori, is one of the highly devastative organism
which causes initial, acute inflammatory reaction followed by chronic
irreversible damage on the underlying surface. The outcomes are variable from
the benign ulceration predisposing to carcinoma and the reactive lymphoid
hyperplasia transforming into gastric lymphomas11.
PEPTIC ULCER:
By definition, a peptic ulcer results from the effects of acid on the
mucosa6 .This may be acute or chronic. An ulcer is termed as “chronic”, when it
is long standing over months and does not heal. Microscopically, the ulcer site
shows inflammatory infiltrates predominantly eosinophils surrounded by the
area of fibrosis. An acute ulcer is merely a reaction to an aggressive pathogen
causing local effects. It’s usually large erosion that has penetrated through the
muscularis mucosa deep into the gastric wall5. Sectioning through
the ulcer site reveals the three distinct zones6. A Superficial zone of necrotic
slough, with fibrin and neutrophils; a Middle zone composed of chronic
inflammatory infiltrates and granulation tissue; the Deep zone consisting of
fibrous tissue with vessels showing endarteritis obliterans.
36
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The gastric ulcers which are benign are accompanied by the areas of acute and
chronic inflammation. The pattern of gastritis differs depending on the site of
involvement. In the pyloric canal & pre pyloric region, there is diffuse antral
gastritis with the presence of helicobacter pylori like organisms. More
proximally, the ulcers in the region of incisura angularis are accompanied by
multifocal atrophic gastritis & intestinal metaplasia. The morphology and
clinical features are common in both the gastric and intestinal ulcers.
At the edge of all ulcers, it’s universal that in all types there can be reactive
changes in the overlying epithelium. The
changes include high N: C ratio, hyperchromasia. This may be confused with
the dysplastic epithelium or malignancy. A focus of intestinal metaplasia may
show foveolae with basal nuclear crowding and increased mitosis similar to
normal small bowel. However towards the surface, the epithelial maturation is
identified. Inflammatory epithelial changes vary depending on severity and
there is gradual transition from normal to atypical; whereas the transition
between the dysplastic and normal epithelium tends to be abrupt. The reactive
epithelium shows nuclei which are vesicular & rounded with one or two
enlarged nucleoli31. Dysplastic nuclei are enlarged, crowded, compressed and
tend to have hyperchromicity. Adjacent to site of peptic ulcer, atypia is noted
more severe in areas of severe inflammation. The dysplasia may also show
37
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focal inflammation, but the less inflamed areas are also equally atypical. When
a clear cut diagnoses can’t be made out, it is termed as indefinite for dysplasia.
The biopsy is done again after treatment with anti inflammatory therapy.
GASTRIC CARCINOMA:
Almost 1 million cases of gastric cancer are diagnosed each year,
elaborating this disease as the 4th most common cancer worldwide irrespective
of the gender29. This is the second leading cause of cancer deaths worldwide.
Though the virulence, etiology and social factors vary according to the region,
the majority of patients succumb due to malignancy. The most common being
the gastric adeno carcinoma. In some regions of the world, gastric carcinoma is
the most common malignancy, & in Japan the incidence is 10- fold higher than
the rates observed in United States34. Typically, the diagnosis is delayed due to
the lack of early specific symptoms, and most patients are diagnosed only after
the cancer has invaded the muscularis propria33.
Histologically, 2 distinct variants of gastric carcinoma have been
identified: Diffuse –type gastric cancer which consists of neoplastic cells that
are individually scattered & do not form glandular structures; and Intestinal-
type adenocarcinoma which involutes through a series of well defined
histological subtypes. Intestinal type adenocarcinomas are initiated by the
transition from normal mucosa to chronic superficial gastritis; followed by the
38
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atrophic gastritis and intestinal metaplasia. This finally leads to the dysplasia
and adenocarcinomas of the gastric epithelium. The histological features seen in
this aspect of malignancy are synonymous to that of the intestinal epithelium
counterpart. They are classified histologically into various subtypes depending
on the pattern of growth and aggressiveness. The pathogenesis is variable and
involves the host response which may turn fatal and also the virulence factors of
the h.pylori, environmental carcinogenesis and other factors, which will be
discussed further.
This form of gastric cancer affects men twice as commonly as
women with a mean age of 50 yrs and 46 yrs respectively26. The corpus
predominant gastritis predisposes individuals towards gastric cancer; whereas
the antrum related infection causes Peptic ulcer disease which shows fewer
predispositions to carcinomas27.
FACTORS DETERMINING THE PROGRESSION TO GASTRIC
CARCINOMA:
There are various factors that mediate the progression of disease
from benign, simple superficial gastritis gradually transforming into an invasive
high grade gastric carcinoma. There is an inter link between the
39
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factors and it is termed a “multi factorial pathway “–explaining the
carcinogenesis37.
ENVIRONMENTAL FACTORS:
These include the H. pylori, helminths, high salt consumption,
cigarette smoking and anti oxidants. Of all these, the H. pylori infection forms
a schematic format, starting from the superficial gastritis and later predisposing
to malignancy. Due to the genetic variations, present within H. pylori genomes,
the bacterial virulence factors often play an important role in determining the
outcome of H .pylori infection. The genome is composed of cag PAI, cagA, vac
A which cause the cytotoxic effects.
The adhesins & Outer Membrane Proteins help in the adhesion of H
.pylori to the gastric epithelium11. Thereby it helps in the initial colonization,
persistence of infection and delivery of virulence factors to host epithelial cells.
Along with Outer Membrane Proteins and adhesins, there is BabA, DupA &
FlaA. These help in causing adhesions, duodenal ulcer promotion and flagellar
movements against the host mucous secretions respectively.  By promoting
these mechanisms, the environmental factors cause initial surface gastritis,
leading to the chronic gastritis. There is increased secretion of acid from G cells
and exhibiting reactive changes microscopically .Then later it progresses to the
atrophy of gastric glands and metaplasia. The
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common being intestinal metaplasia, there can be pyloric metaplasia in pre-
pyloric and gastric antral region .This predisposes to the dysplastic epithelium
and later into an invasive gastric carcinoma19.
HOST FACTORS:
The host exhibits the reactive polymorphisms to counteract the
pathogen. H .pylori induced carcinogenesis includes gastric inflammation and a
reduction in acid secretion. IL-1β a pleiotropic pro inflammatory molecule is
increased in H.pylori infection. This molecule, a potent inhibitor of acid
secretion, is profoundly pro inflammatory, and is up regulated by the H.pylori.
It is regulated by the promoters with informative polymorphisms and thereby
promotes the carcinogenesis.
TNF-α is a pro inflammatory acid – suppressive cytokine that is increased
within H.pylori colonised human gastric mucosa33. Polymorphisms that enhance
the effect of this cytokine expression have now been associated with an
increased risk of gastric cancer and precursor lesions. Also important are the
other cytokines, IL – 10 and IL - 8 which helps in the expression of
carcinogenesis. In addition to the stimulation of cytokine production, H.pylori
also activates pro inflammatory Cyclo oxygenase (COX) enzymes. They
catalyze the key steps in conversion of arachidonic acid to endoperoxidase, a
substrate for a variety of prostaglandin synthase that catalyze the formation of
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prostaglandins and eicosanoids. While COX -2 expressions is inducible and can
be stimulated by a variety of growth factors and pro inflammatory cytokines,
the COX-2 expression is further increased within gastric pre malignant and
malignant lesions. COX inhibitors such as aspirin and NSAIDS decrease the
relative risk of gastric carcinomas. The capacity of COX- 2 generated products
to promote neoplasia is well established, and specific mechanisms utilised by
these molecules include stimulation of proliferation with inhibition of apoptosis.
There is promotion of cellular adhesion, stimulation of angiogenesis and
cellular transformation.
ACID SECRETION:
Acetylcholine, gastrin, & histamine are major stimulants of
gastric acid secretion34. In the gastric corpus, gastrin acts directly on parietal
cells and indirectly acts through release of histamine from ECL cells, which in
turn activates H2 receptors on parietal cells to elaborate the release of acid.
Acetylcholine directly acts on M3 receptors on parietal cells and helps in
secretion of the acid. H.pylori can either inhibit or stimulate the acid secretion,
depending on the context of infection and location. Acute infection is usually
associated with hypochlorhydria which is a result of increased production of the
pro inflammatory cytokines IL-β and inhibition of H+ K+ ATP ase pump. In
case of chronic inflammation, there may be hypochlorhydria or
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hyperchlorhydria depending on the severity and distribution of gastritis. Most
patients with long term infection develop pan gastritis associated with
hypochlorhydria, which may progress to ulceration, dysplasia and cancer34.
A potential contributing factor in the inflammation – to – carcinoma sequence is
the generation of oxidative stress. Oxidative DNA damage induced by H .pylori
infection has been well explained for gastritis. DNA damage has been
demonstrated in the tissues exposed directly to H.pylori38.
H .pylori induces both the humoral and cellular immune responses. Local and
systemic antibody responses have been demonstrated that include IgA, IgM &
IgG isotopes. Macrophages are essential as innate responders to H.pylori
derived products and signals from epithelial cells that are in direct contact with
bacterium on the surface of the mucosa. The effect of MACROPHAGES is
suppressed by the deleterious effect of the pathogen, thereby preventing the
further action of the host12. The organism escapes from the engulfment by
macrophages, inactivates the T cell signals stimulated by them. In the end the
macrophages undergo apoptosis, as a result there is impairment of chronic
inflammatory response and hence predispose to cancer risk13.
The maintenance of tissue integrity requires that enhanced cell proliferation
along with increased rates of cell loss. In chronic H.pylori infection,
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there is lack of epithelial necrosis, suggesting that other forms of cellular
demise may be affected.
Chronic stimulation of MMP-7 by H.pylori in vivo may be seen in a
selective population, who possess hyper proliferating cells with reduced
sensitivity to apoptosis, thereby contributing to increased carcinogenic risk.
Hence, H.pylori is categorised as Class I carcinogen by WHO5.
To summarise, Gastric cancer is a highly lethal disease, and
establishment of H.pylori as a risk factor for this malignancy allows an
approach to identify persons at high risk; however infection with this organism
is extremely common, and most colonized persons never develop cancer. It is
apparent from recent studies that cancer risk is due to cumulative effects of the
polymorphic nature of the bacterial population in the host, the host genotype
and environmental exposures, each affecting the level of long term interactions
between H.pylori and humans22.
GASTRIC LYMPHOMA:
The lymphomas are the more common primary to occur in the
extra nodal site. The common location being the stomach, in body followed by
antrum. Usually it is present as circumscribed nodular lesions over the gastric
mucosa endoscopically. They appear similar to a sessile polyp and gives a
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differential diagnoses clinically. The biopsy reveals the proliferation of
lymphoid precursors with an active germinal canter. It is usually a reactive
process and is seen in almost all cases of H.pylori associated chronic gastritis.
The lesion occurs in the lamina propria where there are increased lymphoid
follicles. On prolonged duration, there could be transformation into malignant
lymphoma of B cell type. There can be presence of several patterns and variants
which could be Diffuse Large B cell lymphoma, lympho-epithelial lesion most
commonly MALT lymphoma17.
GASTRIC PATHOLOGY ASSOCIATED WITH H.PYLORI:
Insult to the gastric mucosa, provokes a variety of inflammatory &
reactive responses that depend on the type, location & duration of the injury.
The correct diagnoses of gastritis rely on the pathologic recognition of various
types of tissue responses, their intensity and location. The common pathologic
tissue reactions of gastric mucosa include 19:
1. Neutrophilic infiltration
2. Mononuclear infiltrates
3. Lymphoid aggregates and follicles
4. Eosinophils
5. Hyperemia and edema
6. Surface erosion
7. Foveolar hyperplasia
8. Intestinal metaplasia
9. Atrophy
10.Endocrine cell / parietal cell hyperplasia
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Neutrophilic infiltration:
The normal gastric mucosa may contain a few neutrophils in the
lamina propria. However, infiltration of the surface epithelium by neutrophils
represents a pathologic response & is considered as an active component of
gastritis19. The term active is used to indicate that there is a continuous release
of inflammatory mediators. This is most commonly due to H.pylori infection,
though many other infections & inflammatory conditions can also cause this.
Active phase of H.pylori induced gastritis may reveal moderate to severe levels
of neutrophils.
In chronic H.pylori gastritis, due to prolonged contact of organism
to the surface, there is irregularity in the epithelial cells exhibiting cuboidal
shape with decrease in mucin, these changes are characteristic and is due to
VacA & cagA, urease, ammonia, etc. There is infiltration of the neutrophils
over the altered surface epithelium and it is the distinctive histological feature.
Neutrophils are more abundant in antrum and cardia, than in corpus; may fill the
lamina propria, could form pit abscesses and surface exudates. The grading of
activity is based on the amount of neutrophils being colonised21. It is termed as
“mild “when the neutrophils are seen limited within the lamina propria. As
“moderate “activity when the neutrophils enter the gastric pits with or
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without abscess formation; and “severe “only when there is ulceration with
associated atrophy of the pit epithelium24.
Mononuclear infiltration:
Normally, the gastric antrum contains few mononuclear inflammatory
cells, whereas normal body mucosa contains virtually none. The presence of
scattered lymphocytes and plasma cells in lamina propria is usually normal. In
contrast, increased cellularity of lamina propria composed of lymphocytes,
plasma cells, variable number of eosinophils and mast cells is characteristic of
chronic H.pylori gastritis11.
Lymphoid aggregates and follicles:
Normal gastric mucosa, particularly the body may contain
occasional small lymphoid aggregates that are separated by delicate septae.
They are usually situated in close proximity to the muscularis mucosa at the
base of lamina propria. In studies performed, the lymphoid aggregates and
follicles have been detected virtually in all subjects with H.pylori gastritis. The
presence of lymphoid follicles is highly specific for H.pylori infection36. In
patients who are children and young adults, lymphoid follicles may be
numerous and are seen endoscopically as nodular lesions14.
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Atrophy:
Gastric atrophy is defined as, “a loss of gastric glands “7. Whenever
gastric mucosa is influenced by prolonged insults, regardless of aetiology, it
may either regenerate to normal or undergo protective metaplastic change.
When chronic pathology persists, the injured glands fail to regenerate and lose
its function. This dysfunctional surface is replaced by the fibroblasts and
extracellular matrix. The native glands may be replaced by metaplastic
epithelium. The common being pyloric or intestinal metaplasia, which is
composed of goblet cells .Several pathology workshops have developed a
method for grading the atrophy in mucosal biopsies. If present, it s
recommended to describe the atrophy, according to its two sub types –
Non metaplastic or Metaplastic.
Metaplasia:
The transformation of one epithelium into other as a protective
mechanism. Two major types are seen in stomach, 1.) Intestinal metaplasia
(IM), 2.) Pyloric metaplasia (pseudo pyloric) 18
PYLORIC metaplasia – there is replacement of the acid and enzyme secreting
cells of fundic glands by mucus secreting glands of pyloric mucosa29. This
change in epithelium occurs in the zone of fundic mucosa, adjacent to the
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fundo - pyloric junction. INTESTINAL metaplasia – there is a change in the
cells of surface and pit epithelium, so that morphologically and histochemically
they resemble the cells of intestinal epithelium17.
There are two types of intestinal metaplasia that are observed. They include
Complete IM and Incomplete IM; termed as Type I and Type II respectively.
In Type I, the gastric mucosa resembles normal small bowel epithelium with
fully developed goblet cells & enterocytes with brush borders. In advanced
cases, there may be development of villi and crypts.
In Type II, there are no absorptive cells seen. The epithelium consists of a
mixture of intestinal type goblet cells and columnar mucus secreting cells,
resembling normal gastric epithelium.
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Type of metaplasia Type of mucin Special stains used
NORMAL
STOMACH
NEUTRAL
MUCIN
PAS + / AB -
COMPLETE
INTESTINAL
METAPLASIA
ACIDIC MUCIN
(SIALO / SULFO
MUCIN )
PAS + / AB +ve
**
AB – ve
INCOMPLETE
INTESTINAL
METAPLASIA
SIALO MUCIN
INCOMPLETE
INTESTINAL
METAPLASIA  (
LARGE BOWEL )
SULFO MUCIN HIGH IRON
DIAMINE
** Alcian Blue is positive at pH 2.5 and negative at pH 0.5 for SIALOMUCIN.
Whereas in case of SULFOMUCIN, Alcian Blue is positive at both pH 0.5 &
2.5. Alcian blue stains blue colour and is seen in normal intestinal mucosa. The
PAS stains magenta colour and is seen in normal gastric mucosa. High Iron
Diamine stains the sulfomucin present in the colonic type of epithelium and is
stained black24.
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The inflammation of the gastric mucosa can be acute and chronic with varying
morphological and histochemical features depending on the duration, aetiology
and environmental factors.
THE UPDATED SYDNEY SYSTEM 9:
The system provides guidelines for providing systematic, uniform
diagnostic reports. It is recommended that at least 5 biopsy specimens should be
evaluated and the findings summarized. This system classifies gastritis on the
basis of topography, morphology and aetiology into 3 broad categories.
1. Acute        2. Chronic     and      3. Special
Chronic gastritis is further divided into ATROPHIC & NON ATROPHIC
gastritis.
Each relevant pathologic feature (density of H.pylori, intensity of neutrophilic
and mononuclear infiltration, atrophy and intestinal metaplasia) should be
graded separately. Each feature is assigned either a numeric or descriptive
value. 0 – for absent
1—for mild
2—for moderate
3—for marked ( or severe )
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The values of each feature are then averaged separately for each anatomic
compartment (antrum and corpus)
Both the 1990 original Sydney System and its updated 1994 version ( also
known as Houston – Updated Sydney System ) provided a structure for proper
description and to substantiate  the primitive lesions , that is , the inflammatory
cell populations and the accompanying changes of the epithelium 17 . There
were inter observer variability among the pathologists, with regards to atrophy.
Atrophy Club 2000 included the sequence of gastric atrophy and intestinal
metaplasia 21.
Peyalo Correa demonstrated that patchy areas of atrophic –
metaplastic changes in antrum and oxyntic mucosa co-exist with gastric ulcer
and in carcinoma sequence. Sydney system also recommended 5 main sites for
the biopsy sample.
1. greater and lesser curvature of distal antrum
2. greater and lesser curvature of proximal corpus and
3. lesser curvature at the incisura angularis
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The above classification of atrophy is based on the recommendations of the
ATROPHY CLUB.
ATROPHY
ABSENT INDEFINITE PRESENT
METAPLASTIC NON   METAPLASTIC
M I L D
M O D E R A T E
S E V E R E
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SYDNEY SYSTEM CLASSIFICATION OF GASTRITIS
NON ATROPHIC ATROPHIC SPECIAL FORMS
H. Pylori Auto immune Chemical
? other factors ? H.Pylori Radiation
Multifocal atrophic
gastritis ( MAG )
Lymphocytic
Non infectious
Granulomatous
Eosinophilic
Others
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Identification of the Organism:
H.pylori is a gram negative, spiral, motile bacterium that
resides in the gastric pits and the overlying mucus11. The early phase of H.pylori
infection exhibits an acute inflammatory response. The patient may be
symptomatic or asymptomatic with nausea and vomiting31. The findings which
alert the pathologist to look for this tiny pathogen include the acute
inflammatory response with lymphoid proliferation, villiform transformation,
regenerative changes and metaplasia48.
These spiral bacilli are picked up in the routine H&E as pink comma shaped
structures that reside over the mucus and pits. Due to increased colonization of
the bacterium there is exaggerated local inflammatory response with pit
abscesses and inflammatory debris. Sometimes, these organisms lie deep inside
the mucus covered by inflammatory debris and polymorhonuclear cells. To
further confirm the presence of these bacilli, various special stains are used. The
most commonly used are Modified Giemsa, Toluidene blue, Warthin Starry
stain, Diff- Quick and Silver based “triple stain”, Genta stain38.
Silver based triple stain: additionally intestinal metaplasia can be detected due
to alcian blue application at acidic pH. These include Acridine orange, Gram
stain, Brown Hopps38.
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In Modified Giemsa, these bacteria are seen as dark blue comma shaped
structure present over the site suspicious for its presence, in routine H&E stain.
This special stain could be counter stained with other dyes to enhance the
visualization32.
In Warthin Starry, the organisms are seen as black spiral structures in a yellow
background 16.These special stains are more sensitive in identifying the
organisms compared to that of routine H & E. Though it is accurate in
diagnosing, there are certain conditions in which the diagnosis could be missed
out. These are discussed further...
Diagnostic limitations 17, 21:
1. Indolent forms – such as coccoid
2. More deeper location within mucus
3. Severe inflammatory response
4. Dirty background filled with nuclear debris
5. Pre- treated patients with scanty bacilli.
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DIAGNOSTIC MODALITIES FOR H.PYLORI:
There are various methods for detection of H.pylori which are both
invasive and non invasive procedures11. The non invasive methods include –
serologic testing, faecal antigen detection and urea breathe testing.
The invasive methods require endoscopy evaluation supplemented with
bacteriologic culture, histopathology studies, smear examination, rapid urease
test and molecular studies32.
Of all the tests described, histopathology examination is now termed gold
standard and more sensitive test for detection of H.pylori 19.
Microbiology – Urease Broth / Urease agar kits, Urease Breath test, PCR /
ELISA
Culture – gastric antral biopsies, cultured in Chocolate agar / Brucella agar with
5% sheep blood / Skirrow‘s and Modified Thayer- Martin medium was
considered once as a gold standard.
With numerous studies and updates done frequently, the idea of provoking the
antigens for H.PYLORI which could be more specific in diagnoses came into
existence.
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IMMUNOHISTOCHEMISTRY – for bacterial detection have been available
since 1988, and is reported as more reliable for the semi- quantitative diagnoses
of H.pylori infection and for the detection of indolent forms of these bacilli9.
This method could overcome certain limitations, though there could be some
inter - observer variations in morphology and lack of experience in
gastrointestinal pathology. The immuno histochemical methods are more easy18,
reliable and less time consuming7. The staining is such that , the organism
stands out well , with well elaborated tissue morphology .The relationship
between H.pylori and gastric cancer had been established (Watanabe et al ,
1998) .Thus the invasiveness of H.pylori aroused the interest among
pathologists. They found that H.pylori antigens progressively migrate from the
cell membrane to the inner cytoplasm with progression of chronic superficial
gastritis pre cancerous lesions gastric cancer.
H.pylori was highlighted by immunohistochemistry; seem to invade the
cytoplasm of epithelium 17. H.pylori changes its shape from spiral to coccoid
forms and may appear indolent leading to malignancy.
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Helicobacter pylori Antibody:
This is concentrated and pre diluted Polyclonal Antibody 28.The
antigen detection, in tissues and cells is a multi step immunohistochemical
reaction. The initial step is binding of the primary antibody to its specific
epitope. After labelling the antigen with a primary antibody at a dilution of 200
µg / ml for 20 minutes at room temperature; a universal affinity purified
secondary antibody is added to bind with the primary antibody forming a
primary antibody – secondary antibody complex. An enzyme label is then added
to bind to the secondary antibody17. This detection of bound antibody is seen by
a calorimetric reaction18.
H.pylori is spiral – curved, gram – negative bacteria that are present on the
surface epithelium of mucous layer of stomach. There is evidence that these
bacteria play an important role in development of peptic ulcer disease 17.
Immunohistochemistry can distinguish H.pylori from other types of curved
bacteria. These small spiral organisms can be seen clearly using high power (40
x) as clusters and on oil immersion (100x) clear morphology is noted and thus
confirms the diagnosis. Both Monoclonal and Polyclonal antibodies are in
existence now, with a slight variation in sensitivity / specificity. Of the two,
monoclonal antibodies seem to be better than the polyclonal antibody as
described by a study 28.
59
RESULTS & ANALYSIS
60
Results & Analysis
This study is done retrospectively over a period of one year duration. A total of
55 cases which are clinically suspected and histochemically positive H.pylori
associated chronic gastritis were selected. The slides were taken from the
department archives and the paraffin blocks of the same, were obtained from
our histopathology laboratory with proper procedures.
The tissue blocks were processed again on plain glass slides and stained with
routine H&E, Modified Giemsa. Combined with the routine stains used for
H.pylori, Antibody against H.pylori was made to assess the density of H.pylori,
the efficacy and sensitivity of the Immunohistochemical staining. Along with
the identification, other suggestive pathological features were also observed
and the results are summarized as follows.
Incidence:
Among the 55 cases studied, there was a MALE predominance with
the age group being 4th and 5th decades [21cases] as depicted in Table (1a, b)
Observations:
The biopsy samples were endoscopy guided, and the tissue is taken
from the gastric antrum & the body with predominant site being Antrum [47
cases] in Table (7). The slides were stained using H&E and Modified Giemsa.
We found that, initial finding was gastritis, showing neutrophilic infiltration
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indicates the activity of inflammation. The gastritis was graded based on
Modified Sydney System as mild, moderate & marked.
Majority of the cases studied under H&E showed MILD activity [31 cases]
(Table 2)
We were also interested to look upon the features suggesting the presence of
H.pylori infection. Hence we searched for the colonization of H.pylori under
H&E and special stains. In our institution, for our routine practice we use
Modified Giemsa as special stain with a positive control for each case. We
looked for the H.pylori colonization in H&E and Modified Giemsa and graded
as mild , moderate and marked depending on the density of the organism
[Table-3] Most of the cases showed only MILD colonization of H.pylori under
routine stains ( H&E and Modified Giemsa ).
There were marked changes in the mucosa at the site of inflammation,
associated with H.pylori manifestation. The changes include Intestinal
Metaplasia, Lymphoid follicles, villiform transformation. Out of all the above
mentioned features, there were increased lymphoid follicles with active
germinal centre, in a dominant 41 cases, followed by Intestinal Metaplasia (33
cases) and Villiform transformation.
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There was no finding of atrophy in the cases studied, as atrophy is considered, a
pre dysplastic lesion. [Table 6]. When compared with the site, the majority
being antrum, the commonest site for H.pylori colonization. There were
combined features in many cases having both villiform transformation and
intestinal metpalasia; lymphoid follicle formation is seen in many cases
irrespective of other co-existent pathological features. Thereby making this as
the diagnostic feature for chronic H.pylori gastritis.
Helicobacter pylori Antibody was used to compare the sensitivity of routine
H&E and Modified Giemsa. We looked for all those features mentioned above
and compared with the results against the routine stains.
Using H.pylori antibody, there was MARKED intensity in staining and
it was easy to pick up these spiral organisms compared to routine stains
[Table 4]. The sensitivity and specificity was much higher than the routine H&E
and histochemical studies. The time consumption was less and diagnosis was
more accurate than the routine stains .Thereby it reduces the risk of reporting
false positive cases. This antibody also elicits the organisms residing in deeper
mucus glands, situated within the debris and in scant colonization. There are
some cases in patients who are on treatment with PPI, the spiral organism, takes
up a different shape and structure to hide from the host response; the common
being coccoid forms. The IHC, provokes an Antigen –
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Antibody reaction and lightens up all the H.pylori organisms residing over the
gastric mucosa irrespective of the clinical status of the patient.
To concise, 55 clinically suspected and histopathologically diagnosed cases
were taken for this study.
We found there is MALE predominance, with the age group being 4th to 5th
decade, and common site being GASTRIC ANTRUM.
In the sections studied, on H&E, there was MILD activity in 31 cases out of 55
followed by Moderate activity in around 20 cases.
When H.pylori like organisms was visualized on H&E, Modified Giemsa and
Immunohistochemistry we graded the colonization of bacilli on each stain
separately.
The Routine stains (H&E and Mod. Giemsa) showed MILD colonization in
around 37 cases. Whereas there was MARKED colonization in majority of
cases stained with antibody. (34 cases).
The other pathological features were noted, and we found there was an
increased lymphoid follicle in around 41 cases, followed by Intestinal
metaplasia. There were also mixed overlap in features, many lesions having
lymphoid follicles in common with other features in permutations.
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H.pylori infection is one of the major aetiology for asymptomatic
chronic gastritis in the developing countries2. This is mainly due to varying
etiologic factors and diverse environmental parameters. The most common age
group for this disease is children and young adults as described by literature 4.
But this data varies accordingly depending on different parts of the world. As a
whole, many patients presented with vague abdominal discomfort, dyspepsia
and GERD like symptoms17. It is described by WHO as Grade I carcinogen and
its susceptibility to cause malignant transformation14. Early diagnosis and
treatment would play a vital role in the prevention of disease progression.
Endoscopically, the gastric mucosa usually shows intestinal
metaplasia like areas with or without nodular fleshy lesions suspicious for
H.pylori infection24. These areas exhibit an irregular squamo columnar junction
with a salmon pink tongue extending into the tubular esophagus24. Usually
H.pylori infection is clinically assumed as one of the prime differentials in a
patient with mild symptomatic or asymptomatic chronic gastritis. Hence, the
patient is given a prophylactic H.pylori eradication therapy composed of triple
drug “O T C kit “[Omeprazole, Tinidazole & Clarithromycin]. The therapy is
for 2 weeks initial triple drug followed by 4 weeks of oral Proton Pump
Inhibitors31. The PPI’s itself cause effects on the gastrin secreting cells thereby
causing altered secretion of gastric acid. This also takes toll on H.pylori making
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the organism pleomorphic by changing its morphology into a Coccoid form17.
This form of H.pylori is difficult to identify as it is too small and may lie with
the inflammatory cells. When there is recurrence of symptoms or progression,
the endoscopy biopsy are taken, common sites being Antrum and Body. The
histopathology diagnosis is more specific and is supplemented by other
biochemical tests. In histopathology, routinely the sections are examined on
H&E and Modified Giemsa over years. But now, in the era of modern medicine
and broader scope for research, new inventions are on periodically. Due to
increased risk of carcinogenesis by H.pylori these is an urge to find a method to
increase the specificity on detection.
A few studies done before (Lu Xin et al; Intisar S.Pity et al; Ali k.
Riba et al) stated the importance of the Antigen – Antibody reaction on the
H.pylori and the application of polyclonal antibody in current practice26. They
also stated that the antibodies are more advanced, easy to interpret, high
sensitivity and specificity than histochemical stains. Though there are more
positive aspects, no studies have suggested the necessity and the need to include
this in routine diagnosis of H.pylori. This provoked the interest to do this study
and add our information on comparing the IHC with special stains (Modified
Giemsa) and H&E. We also observed the histopathological changes that are
seen in H.pylori associated chronic gastritis. The common changes
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include gastritis, oedema, hyperaemia, congestion, metaplasia, lymphoid
activity and dysplasia11. These features occur as a sequence of events. In this
study, we explain the incidence of each finding, their associated features,
intensity/ severity of the organism and various etiologic factors we observed in
our set up or locality.
Inflammation:
On routine H&E, we found the inflamed gastric mucosa infiltrated by
neutrophils due to release of interleukins. All the cases showed inflammation
with slight variation in severity, and we graded them according to Modified
Sydney System. Out of 55 cases studied, most of the cases showed MILD
inflammation, followed by moderate inflammation. The severe or marked
inflammation was seen only in about 4 cases. There was dense inflammatory
response over the surface. Some studies say that there could be an overlying
ulceration covered with slough. But in this study we did not find any case
showing active ulceration. This variation may be due to prophylactic use of PPI,
or environmental variation.
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Metaplasia:
Due to chronic irritation of gastric mucosa, the host tries to respond
against the pathogen by stimulating the chemokines, and mucus secretion. As
this process prolongs, the normal surface epithelium changes itself into other
viable forms which are capable of surviving the prolonged insult. This process
is termed as “metaplasia”. The common types of metaplasia are: Intestinal and
pyloric. The intestinal metaplasia is more common of the two.
Normally, the gastric mucosa contains Neutral mucin which is
positive for PAS27. When there is transformation into intestinal type of
epithelium, there is increased goblet cell formation which is similar to that of
intestine.
The goblet cells contain acidic mucin (sialo / sulfo) depending on the
pH. The goblet cell metaplasia is confirmed using AB / PAS stain. The gastric
mucosa shows positive for PAS (magenta colour) and the adjacent goblet cells
exhibit Alcian Blue positivity (blue colour).
In our study, there were only intestinal metaplasia and no case of pyloric
metaplasia was seen. Intestinal metaplasia was seen in 33 cases marking about
60 % of the total 55 cases studied. This is further termed separately as mild,
moderate and marked according to Sydney System.
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Atrophy -- It is defined as, “the loss of glands “.
Atrophy is usually termed as an end result of chronic gastritis, common
aetiology being H.pylori infection. It stands intermediate between metaplasia
and dysplasia.
There are many studies quoting on the importance to look for atrophy. They
point out that atrophic gastritis could turn malignant.
In our study, no case showed glandular atrophy.
Lymphoid aggregates and follicles:
Lymphoid aggregates are seen scattered in normal gastric mucosa.
In studies, they stated that virtually many lymphoid follicles are seen in all cases
of H.pylori gastritis. This feature is highly specific for H.pylori infection.
In our study, we found majority of cases showing active lymphoid
follicles consistent with the literature 36 . Out of 55 cases, 41 cases (74.5 %)
showed lymphoid follicles, which were consistent with nodules, endoscopically.
We also noted the Villiform transformation in around 9 cases (16.3 %) out of
55 cases studied.
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Interpretation:
To correlate with the H&E findings suspicious for H.pylori
aetiology, we used Histo & Immunohistochemistry. The Modified Giemsa and
H.pylori antibody were used.
We looked for the staining of organism in both the stains and
compared the sensitivity / specificity between both stains.
To start with, we used the routine H&E , the site suspicious for H.pylori
infiltration were noted , examined further using the special stain and IHC . The
need of the study is fulfilled at this stage, when we analysed the intensity of the
bacilli in both Modified Giemsa and IHC.
In this study, we implement the simultaneous use of Monoclonal Ab
for H.pylori along with Modified giemsa. When compared, the Antibody was
much better than the routine stains. The intensity was more superior, the
colonization of the bacilli was seen clearly, especially in the areas of thick
mucus and near the pits16.
Out of 55 cases studied, Modified Giemsa showed MILD
bacterial colonization in majority of cases (37), whereas H.pylori antibody
proved that there were intensely MARKED colonization in most cases (34).
Thereby, it helps in the exact staging of disease and proper grading of
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inflammation. Immunohistochemistry acts as a specific diagnostic tool in cases
of H.pylori induced chronic gastritis.
We meticulously searched for the bacilli and other associated histological
features. The findings were classified accordingly and separate grading was
used in each pathological feature as suggested by Modified Sydney
classification.
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To summarize,
 In this study on 55 cases of H.pylori associated chronic gastritis, spanning
1 year duration there was MALE predominance with age group being 4th
to 5th decade.
 The common site being GASTRIC ANTRUM.
 Comparing with routine H&E and Modified Giemsa, Antibody against
H.pylori showed higher sensitivity exhibiting MARKED colonization in
majority of cases, which were previously thought as MODERATE in
Modified Giemsa.
 On observing the pathological changes, we found predominantly
LYMPHOID FOLLICLES in almost all cases.
 Other features indicating H.pylori associated chronic gastritis such as
Metaplasia (commonly Intestinal), villiform transformation were also
noted.
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Though there are number of methods for detection of H.pylori,
Histopathology is always the gold standard. To add it on, use of
Immunohistochemistry would increase the specificity and also reduces the false
negative results.
Thus by using the H.pylori antibody in routine practice along with
Modified Giemsa, the diagnosis could be made easily, more specifically and
quickly.
In the developing countries, though the feasibility is low due to
cost, we would suggest that implementation of IHC as a routine in near future
would help in providing an early diagnosis and appropriate treatment for
H.pylori associated chronic gastritis.
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Table 1a
TOTAL CASES = 55
MALE PATIENTS = 34 (62 %)
FEMALE PATIENTS = 21 (38 %)
In the cases studied, there is MALE predominance.
62%
H.pylori Associated gastritis
38%
FEMALE
MALE
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AGE
(RANGE )
No. of cases clinically / endoscopically
suspected
Positive for H.pylori
associated  gastritis
10 – 20 yrs 04 04
21 – 30 yrs 03 03
31 – 40 yrs 11 11
41 – 50 yrs 21 21
51 – 60 yrs 14 14
61 – 70 yrs 02 02
Table 1 b
Average predominance of age group is 4th to 5th Decade and it is about 21 out
of 55 cases studied.
77
Total=55cases
Table 2a
Inflammation No. of cases Percentage
MILD 31 56.3 %
MODERATE 20 36.3%
MARKED 04 7.2 %
Table 2b
0%
10%
20%
30%
40%
50%
60%
MILD MODERATE
PATTERN OF INFLAMMATION
MARKED
MILD
MODERATE
MARKED
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Of total 55 cases studied, majority of the cases showed MILD inflammation
(31 cases) contributing around 56 %.
The Pattern of inflammation was studied based on MODIFIED SYDNEY
GRADING, which emphasise the use of MILD, MODERATE & MARKED on
each parameter considered.
In the chart above, these terminologies were used to grade the severity of
inflammation.
In the context described below, the colonization of H.pylori organism is
categorised, again using the three grades.
H.Pylori
colonization
No. of Cases Percentage (%)
MILD (++) 37 67.27%
MODERATE
(+++)
13 23.63%
MARKED (++++) 05 9.09 %
Table 3
In the Table 3a described above, out of the 55 cases studied, majority of them
showed MILD H.pylori colonization when studied under routine H&E and
Modified Giemsa stains.
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H.pylori density:
(+/++)Mild – Scattered spiral organism
(+++) Moderate – Moderate colonization covering 1/3rd to 2/3rd of mucosal
surface
(++++) Marked – Dense colonization > 2/3rd of mucosal surface
Routine Stains (H&E and Modified Giemsa)
Table 4
23%
9%
H.pylori Colonization
68%
MILD
MODERATE
MARKED
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USE OF H.PYLORI ANTIBODY
H.PYLORI ANTIBODY No. Of Cases Percentage (%)
MILD 03 5.45%
MODERATE 18 32.72%
MARKED 34 61.81%
Table 5a
In the above table, we looked for the H.pylori colonization using the H.pylori
Antibody. This is to compare the intensity with the routine stains explained in
Table 3. The grading is done again into Mild, Moderate and Marked.
Table 5b
MARKED,
62%
MILD, 5%
MODERATE,
3%
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COMPARISON OF INTENSITY ON H&E, MODIFIED GIEMSA AND
H.PYLORI ANTIBODY
BACTERIAL
COLONIZATION
H & E MODIFIED
GIEMSA
H.PYLORI
ANTIBODY
MILD 42 (76.3%) 37 (67.2 %) 03 (5.4%)
MODERATE 09 (16.3%) 13 (23.6 %) 18 (32%)
MARKED 04 (7.27%) 05 (9.09%) 34 (61.8%)
Table 6a
Table 6b
-5.00
5.00
15.00
25.00
35.00
45.00
55.00
42.00
37.00
9.00 4.00
MILD
MILD
MODERATE
MARKED
3.00
13.00 18.005.00
34.00
MODERATE MARKED
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Histopathological Changes associated with H.pylori infection
Pathology
of Gastritis
No. of Cases Percentage (%)
Lymphoid
follicles
41 74.5%
Intestinal
metaplasia
33 60%
Villiform
transformation
09 16.3%
Atrophy nil nil
Table 7a
Out of 55 cases studied, around 74.5 % showed increased lymphoid follicles in
lamina propria some with active germinal centres.
Followed by Intestinal metaplasia, this is seen in many cases and probably acts
as a clue to the diagnosis of H.pylori associated gastritis (60%).
Villiform transformation, one of the late reactions in the chronic gastritis was
observed in around (16.3%).
No evidence of atrophy was seen in the study.
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Table 7b
Site of
Biopsy
H.pylori / chronic gastritis Intestinal
Metaplasia
Lymphoid
aggregates/
follicles
Villiform
transformationNo
(0)
Mild
(1)
Moderate
(2)
Marked
(3)
Antrum
(47)
0 12 32 03 32 36 07
Body
(8)
0 01 06 01 01 05 02
Table 8a
60%
16%
75%
Lymphoid follicles
Intestinal metaplasia
Villiform transformation
Atrophy
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Table 8b
‘
0
5
10
15
20
25
30
35
40
Antrum (47) Body (8)
Intestinal metaplasia
Lymphoid follicles
Villiform transformation
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Figure 1 H&E 40 x comma shaped H.pylori like organisms
(arrow)
Figure 2. Modified Giemsa (40x).Blue comma shaped
organisms (arrow)
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Figure 3a. H.py;ori Ab (5 x) Shows positivity for H.pylori
Figure 3b.H.pylori Ab (10 x) strong, marked (++++) positivity
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Figure 3c. H.pylori Ab. Marked colonization. Inset – higher
magnification
Figure 3d. H.pylori Ab  (40x). Mild colonization ( arrow )
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Figure 4. H&E (40x) . Moderate activity (arrow). Inset- Neutrophils entering the crypt
Figure 5. H&E  Lymphoid follicles. Inset- lymphoid follicles
with germinal centre.( higher magnification)
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Figure 6a H&E 10x villiform transformation (arrow) . Inset
shows intestinal metaplasia ( arrow)
Figure 6b villiform transformation. Intestinal metaplasia
( arrow)
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S.No Number
id
Age/Sex Site of
Biopsy
H & E Mod. Giemsa H.pylori Ab Other findings
1. S-4359 16/M ANTRUM H.pylori like
organism+
+++ in lining
epithelium
++++ Mild lymphoid follicle .
Intestinal metaplasia
2. S-4594 52/M ANTRUM H.pylori like
organism+
++ on surface ++++ Lymphoid hyperplasia
3. S-3012 56/F ANTRUM H.pylori like
organism+
++ +++ Focal villiform
transformation
4. S-3476 18/M ANTRUM H.pylori like
organism+
+ occasional
H.pylori like
organism
++ -
5. S-3497 19/M ANTRUM H.pylori like
organism+
++ ++++ Focal villiform
transformation /
intestinal metaplasia
6. S-4251 46/M ANTRUM H.pylori like
organism+
+ +++ Lymphoid aggregates
7. S-4798 48/F ANTRUM H.pylori like
organism+
++ ++ Intestinal metaplasia
8. S-3555 48/F ANTRUM H.pylori like
organism+
++ +++ Lymphoid follicles
9. S-4675 41/M BODY H.pylori like
organism+
+ +++ Lymphoid follicles
10. S-5119 32/F ANTRUM H.pylori like
organism+
++ ++++ Lymphoid aggregates,
intestinal metaplasia
11. S-5222 38/M ANTRUM H.pylori like
organism+
+++ on surface
epithelium
++++ Intestinal metaplasia
12. S-4571 24/F ANTRUM H.pylori like
organism+
+ over mucus +++ Lymphoid aggregates
13. S-5145 28/M BODY H.pylori like
organism+
+ occasional
organism
+++ Intestinal metaplasia
14. S-3335 34/M ANTRUM H.pylori like
organism+
Vague
positivity
++ Intestinal metaplasia
15. S-4214 33/M ANTRUM H.pylori like
organism+
+++ ++ Lymphoid follicles
16. S-4366 39/F ANTRUM H.pylori like
organism+
++ ++++ Lymphoid follicles
17. S-5107 41/M ANTRUM H.pylori like
organism+
+/- ++ Focal villiform
transformation
18. S-4872 43/F ANTRUM H.pylori like
organism+
+/- + Lymphoid aggregates
19. S-5090 43/M ANTRUM H.pylori like
organism+
++ over
surface
+++ Intestinal metaplasia
20. S-4813 49/M ANTRUM H.pylori like
organism+
+++ in gastric
pits
+++ Lymphoid follicles
MASTER CHART
S.No Number
id
Age/Sex Site of
Biopsy
H & E Mod. Giemsa H.pylori Ab Other findings
21. S-4410 50/M ANTRUM H.pylori like
organism +
+ over surface
mucus
+++ Lymphoid follicles,
Intestinal metaplasia
22. S-3321 20/F BODY H.pylori like
organism +
++ seen in
gastric pits
+++ Lymphoid aggregates
with moderate activity
23. S-2942 24/M ANTRUM H.pylori like
organism+
+++ over lining
epithelium
++++ Focal villiform
transformation
24. S-2783 44/M ANTRUM H.pylori like
organism+
+++ over lining
epithelium
++ in pits Mild activity
25. S-5005 49/F ANTRUM H.pylori like
organism+
++ +++ Mild activity,
suggestive changes
26. S-4537 41/M ANTRUM H.pylori like
organism+
+++ over
surface
++ scattered
rods in the
pits / debris
Intestinal metaplasia
27. S-4867 43/M ANTRUM H.pylori like
organism+
+ over gastric
pits
++ scattered
in surface
epithelium
Lymphoid aggregates
28. S-3538 46/M BODY H.pylori like
organism+
++ over
surface mucus
++ Moderate activity
29. S-4548 49/M ANTRUM H.pylori like
organism+
+++ over
gastric pits
++ Focal intestinal
metaplasia
30. S-4422 50/M BODY H.pylori like
organism+
++ ++ scattered
over surface
Lymphoid follicles in
lamina propria
31. S-4563 58/M BODY H.pylori like
organism+
+++ + seen over
surface
mucus
Intestinal metaplasia
32. S-5227 60/M ANTRUM H.pylori like
organism +
++ +++ in
surface
epithelium
Intestinal metaplasia,
lymphoid aggregates
33. S-4999 55/F ANTRUM H.pylori  like
organism+
++ + over pits
++ in mucus
Focal Intestinal
metaplasia
34. S-4365 56/M BODY H.pylori like
organism+
+ ++ Focal villiform
transformation,
lymphoid follicles
35. S-4895 57/F ANTRUM H.pylori like
organism+
++ +++ in
surface
epithelium
Intestinal metaplasia,
lymphoid aggregates
36. S-3418 51/M ANTRUM H.pylori like
organism+
+++ ++++ Lymphoid aggregates
37. S-3056 49/F ANTRUM H.pylori like
organism+
++ +++ in pits Focal villiform
transformation
38. S-2197 44/M ANTRUM H.pylori like
organism+
+++ ++ over
surface
Lymphoid aggregates
39. S-2739 46/F ANTRUM H.pylori like
organism
++ +++ Lymphoid aggregates
40. S-3488 44/M ANTRUM H.pylori like
organism+
+ +++ Moderate activity,
lymphoid aggregates
S.No Number
id
Age/Sex Site of
Biopsy
H & E Mod. Giemsa H.pylori Ab Other findings
41. S-4611 51/M ANTRUM H.pylori like
organism+
+ over the
surface
++ in pits Foveolar hyperplasia,
Mild activity
42. S-4874 53/M ANTRUM H.pylori like
organism+
+ ++ in pits Lymphoid aggregates
in lamina propria
43. S-3440 58/F BODY H.pylori like
organism+
+ on surface
epithelium
++ in pits Lymphoid aggregates
44. S-3524 59/F ANTRUM H.pylori like
organism+
++ +++ Lymphoid follicles in
lamina propria
45. S-3067 60/M ANTRUM H.pylori like
organism+
++ in pits + Intestinal metaplasia
46. S-5062 61/F ANTRUM H.pylori like
organsism+
+++ +++ Intestinal metaplasia,
Focal villiform
transformation
47. S-3562 40/M ANTRUM H.pylori like
organism+
+++ +++ in pits Lymphoid follicles in
lamina propria
48. S-3581 37/F ANTRUM H.pylori like
organism+
++ over
surface
+++ Focal Intestinal
metaplasia
49. S-5043 36/M ANTRUM H.pylori like
organism+
++ +++ Lymphoid aggregates
in lamina propria
50. S-4836 35/M ANTRUM H.pylori like
organism+
++ +++ Lymphoid aggregates
51. S-4878 20/M ANTRUM H.pylori like
organism+
+++ ++ over
debris
Mild activity
52. S-3132 33/M ANTRUM H.pylori like
organism+
+++ ++ Mild activity
53. S-3534 31/M ANTRUM H.pylori like
organism+
++ +++ Lymphoid aggregates
54. S-1077 41/M ANTRUM H.pylori like
organism+
+++ over
surface
+++ Lymphoid aggregates
in lamina propria
55. S-3555 48/M ANTRUM H.pylori like
organism+
++ +++ Focal villiform
transformation ,
moderate activity
